Navigation Links
RRD Announces Move to New Corporate Headquarters
Date:9/9/2010

ROCKVILLE, Md., Sept. 9 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that they have moved to expanded offices this month.  The new office space, located at 7361 Calhoun Place, Rockville, MD, recently completed build-out and more than doubles RRD's business footprint to 13,000 sq ft.

"This move is symbolic of the growth and success RRD has achieved in the last year," said Scott Tarrant, Chief Business Officer, RRD International. "Our model has proven time and again to be more efficient and successful than traditional methods, and the market's increasing demand for RRD services necessitated finding a new space to accommodate our growing needs."

RRD International delivers tactical, regulatory-driven product development support to companies and investors in the life sciences industry. Leveraging its in-house strategic and operational expertise, the Company helps clients better plan, manage and execute product development. Having successfully completed more than 80 product development engagements with a wide range of organizations, RRD International's fully integrated development team works to enable rapid proof of concept, reduce costs, and accelerate value creation.

"Times of growth and change are always exciting," added Chuck Finn, President and CEO, RRD International.  "We're thrilled to have found a place that lets us remain in Rockville and better serve our clients and partners."

About RRD International

Founded in 2002, RRD is a strategy-driven product development company. The Company's development model enables rapid proof of concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk. RRD offers two distinct types of client engagements: TacDev® and DevCo®. The TacDev® model adds development bandwidth and expertise for defined
'/>"/>

SOURCE RRD International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd.
2. Martek Announces Third Quarter FY 2010 Financial Results
3. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
4. Medisafe 1 Technologies Announces 1-5 Stock Dividend
5. DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System - Orcathermâ„¢
6. EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors
7. Biodel Announces Name Change for Lead Product Candidate
8. Enerkem Announces Construction Start of Worlds First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
9. MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
10. Glenmark Announces the Discovery of a Novel Chemical Entity GRC 17536, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally
11. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 The report expects global cell ... 2019. It also provides a carefully analyzed data about ... for the market. , Full Copy of Report @ ... global market for cell expansion will keep witnessing growth ... this growth to be driven by rapid technological advancements, ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
(Date:12/24/2014)... PharmaBoardroom,s new report, , ... available for free download , digs deep into this ... in the sector today. One area where ... in developing a homegrown pharmaceutical manufacturing base, even if the ... some way off. A cursory comparison with neighboring ...
(Date:12/24/2014)... 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... Clinical Trial Application (CTA) with the United ... seeking regulatory approval to initiate clinical trials for the ... Contingent on the Company receiving CTA regulatory approval, ... to assess the safety, tolerability and dose escalation of ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... - To better reflect its mission of funding ... used technological term, the Center for Technology Transfer in ... , ,The private, nonprofit organization provides investment funding ... energy-saving technologies, and need assistance to bring their products ...
... Madison, Wis. - Medical imaging technology provider GE ... new molecular imaging agent for the detection of cancer. , ... to track the process of angiogenesis, or the formation of ... to quantify therapy for Stage IV metastatic tumors in breast ...
... - As part of its $6 billion national effort, ... extend coverage to customers in Wisconsin and Illinois. , ... when Cingular invested more $300 million in the state and ... Wisconsin. , ,Since the start of 2006, nine cities have ...
Cached Biology Technology:
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood ... for quite a while. Hypertension – the medical term for ... in the early 1800s, and the inflatable cuff that,s used ... That doesn,t, however, mean there,s nothing new about hypertension, its ... some long-held beliefs about the condition and the best ways ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... role in the spread of disease and in the ... radical theories about nanobacteria ?micro-organisms considerably smaller than ordinary ... articles in the Journal of Proteome Research by Dr ... and Professor Chandra Wickramasinghe of Cardiff University, UK. , ...
... The first `next generation' MRI (magnetic resonance imaging) body scanner ... later this week (Friday 18 th February). , The Achieva ... Manchester and will be used by researchers to further their ... , The state-of-the-art technology involved will revolutionise the way scanning ...
... St. Louis have learned that a temporal "window of ... diabetic rats with embryonic pig tissues. , In those ... that they didn't have to give anti-rejection drugs to ... had expected rats that received no immune suppression would ...
Cached Biology News:Nanobacteria in clouds could spread disease, scientists claim 2Next Generation Body Scanner Launched By The University Of Manchester 2Next Generation Body Scanner Launched By The University Of Manchester 3Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... a compact, versatile system that simultaneously harvests ... 24-well microplates into a solid filter supports ... and gamma counter. The FilterMate is ideal ... such as cell proliferation, receptor binding, nucleic ...
... base medium for preparation of minimal and synthetic ... does not contain amino acids. Both bulk and ... contains reagents to prepare 500 ml of 10X ... 10X YNB for S. cerevisiae media. Store at ...
... based screening project: , 384 ... 96 shape-diverse mixtures of 4 (5 uL each) , ... Individual compounds are dissolved in DMSO at ... Supplied in 5 96-well trays. Dilute library with ...
... Assay Kits are ideal for studying ... compounds using fluorescence polarization (FP) The ... glutathione transferase to the ligand binding ... and a proprietary, fluorescently-tagged progesterone ligand, ...
Biology Products: